Faculty of Health Sciences, Kristianstad University, 291 88, Kristianstad, Sweden.
Institute of Health and Care Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Support Care Cancer. 2024 Jun 18;32(7):442. doi: 10.1007/s00520-024-08631-y.
The aim of this study was to explore patients' experience of participation in the treatment decision of proton beam therapy versus conventional radiotherapy.
Proton beam therapy (PBT) has become a treatment option for some cancer patients receiving radiotherapy. The decision to give PBT instead of conventional radiotherapy (CRT) needs to be carefully planned together with the patient to ensure that the degree of participation is based on individuals' preferences. There is a knowledge gap of successful approaches to support patients' participation in the decision-making process, which is particularly important when it comes to the situation of having to choose between two treatment options such as PBT and CRT, with similar expected outcomes.
We conducted a secondary analysis of qualitative data collected from interviews with patients who received PBT for their brain tumor. Transcribed verbatims from interviews with 22 patients were analyzed regarding experiences of participation in the decision-making process leading to PBT.
Participants experienced their participation in the decision-making process to a varying degree, and with individual preferences. Four themes emerged from data: to be a voice that matters, to get control over what will happen, being in the hand of doctors' choice, and feeling selected for treatment.
A decision for treatment with PBT can be experienced as a privilege but can also cause stress as it might entail practical issues affecting everyday life in a considerable way. For the patient to have confidence in the decision-making process, patients' preferences, expectations, and experiences must be included by the healthcare team. Including the patient in the healthcare team as an equal partner by confirming the person enables and facilitates for patients' voice to be heard and reckoned with. Person-centered care building on a partnership between patients and healthcare professionals should provide the right basis for the decision-making process.
本研究旨在探讨患者参与质子束治疗与常规放射治疗决策的体验。
质子束治疗(PBT)已成为一些接受放射治疗的癌症患者的治疗选择。与患者一起仔细计划给予 PBT 而不是常规放疗(CRT)的决定,以确保参与程度基于个人偏好。在支持患者参与决策过程方面,成功方法的知识差距仍然存在,当涉及到必须在两种治疗选择(如 PBT 和 CRT)之间做出选择的情况时,这一点尤为重要,因为这两种治疗选择的预期结果相似。
我们对接受脑部肿瘤 PBT 治疗的患者访谈中收集的定性数据进行了二次分析。对 22 名患者访谈的转录逐字稿进行了分析,以了解他们在 PBT 决策过程中的参与体验。
参与者在不同程度上体验了他们的参与决策过程,并且具有个人偏好。从数据中出现了四个主题:成为有影响力的声音、获得对将要发生的事情的控制、由医生的选择掌控、感觉被选中接受治疗。
选择 PBT 治疗可能被视为一种特权,但也可能会带来压力,因为它可能会带来对日常生活产生相当大影响的实际问题。为了让患者对决策过程有信心,医疗团队必须包括患者的偏好、期望和体验。通过确认患者的身份,让患者作为平等的合作伙伴参与医疗团队,使患者的声音被听到并得到重视。以患者和医疗保健专业人员之间的伙伴关系为基础的以人为本的护理应该为决策过程提供正确的基础。